WONDERLAB Announces a Strategic Partnership with New Zealand’s GMP Pharmaceuticals, Witnessed by New Zealand’s Minister for Trade

WONDERLAB has long upheld high global standards in raw-material selection and international manufacturing, with strict control over raw-material and product quality. On November 7, at the New Zealand–China Business-to-Business Partnership event held in Guangzhou, New Zealand Minister for Trade Todd McClay, who had just completed a visit to Shanghai and attended the China International Import Expo, and New Zealand Ambassador to China Grahame Morton attended and witnessed the establishment of a nutrition and health industry alliance between WONDERLAB and GMP Pharmaceuticals. The strategic partnership combines WONDERLAB’s influence and industry strengths in China’s nutrition products market with GMP Pharmaceuticals’ global raw-material resources and high-standard international production and manufacturing capabilities. The two parties will continue to develop the global expansion of high-quality products, pursue mutual benefit, and jointly promote the development of the nutrition industry.

Signing ceremony for WONDERLAB and New Zealand’s GMP Pharmaceuticals

New Zealand is renowned for its high-quality natural ecosystems, which provide unique and favorable natural environments for cultivating microorganisms such as probiotics. The country also has a complete and mature R&D and manufacturing industry for probiotics and nutritional supplements. The strategic partnership between WONDERLAB and GMP Pharmaceuticals creates additional business opportunities and new prospects for bilateral trade between New Zealand and China. By deepening cooperation in product innovation and manufacturing, the partners will also create more high-quality, internationally oriented products for consumers in both countries and around the world.